Ayurveda for Flu Like Illness During Covid-19 Outbreak
Not Applicable
Completed
- Conditions
- Flu Like Illness
- Interventions
- Dietary Supplement: AyurvedaOther: Usual Care
- Registration Number
- NCT04351542
- Lead Sponsor
- Aarogyam UK
- Brief Summary
This study aimed to evaluate the efficacy and safety of Ayurveda in reducing symptoms of flu like illness during the Covid 19 outbreak.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
- Patients with fu like symptoms within 48 hours of onset during March2020
- Mild to moderate symptoms who were advised to self isolate at home for 7-14 days
- Flu like symptoms present at least one respiratory symptom (e.g. cough, nasal obstruction, sore throat) and at least one constitutional symptom other than fever (e.g. fatigue, headache, myalgias) of less than 48-hour duration
- Willing to consent and follow up
Exclusion Criteria
-
Pregnant/lactating
- Participants with chronic pulmonary diseases or critical condition or already developed severe respiratory distress
- Clinically malignancies, systemic infection, other medical or psychiatric condition which places the subject at unacceptable risk to participate in the study - Known hypersensitivity to any ayurveda herbal substances
-
Severe symptoms of respiratory distress patients deemed to require intensive care immediately
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ayurveda Care Group Ayurveda Individualised ayurveda treatment was given to participants based on individual constitution. Usual Care Group Usual Care Participants followed the usual care. Ayurveda Care Group Usual Care Individualised ayurveda treatment was given to participants based on individual constitution.
- Primary Outcome Measures
Name Time Method Severity of symptom score Change from baseline to 3rd and 7th day Symptoms diary card completed twice daily from Day 0 to Day 7
Time to achieve afebrile Change from baseline to 3rd and 7th-day Time to bring down a fever (oral temperature \< 37.2 ̊C)
- Secondary Outcome Measures
Name Time Method Patient reported improvement Change from baseline to 3rd and 7th-day Patient reported improvement using 4 scale; 0-none, 1-weak, 2-medium, 3-strong
Trial Locations
- Locations (1)
Aarogyam
🇬🇧Leicester, United Kingdom